Stock News

International Resources Holdings must state whether it intends to bid by 5 p.m. GMT on Nov. 17 under Irish takeover rules.

Agency feedback follows a Phase 3 miss in congenital hyperinsulinism; Rezolute will weigh its filing strategy after tumor HI data.

The New Zealand explorer reports a 3.6-metre true width and aims to update Auld Creek's resource estimate in the fourth quarter.

The 8.5 per cent property loan matures in April 2034 and puts cultivation sites in Johnstown and Palatka behind the debt.

Strive reported 13,498,082 SATA shares on Oct. 2, up 1,304,902 in a week; the indicated dividend rate can change.

The 10 million shares came from John Tognetti and Kenorland's chief executive at C$2.22 each; Kenorland issued no new shares in the purchase.

The Oct. 5 guidelines set bitcoin at about 85 to 90 per cent of assets, while equity remains the main source of new coin funding.

The company plans to leave the TSX Venture Exchange after Oct. 6, while shareholders keep their existing certificates and security identifiers.

The final 35 regional holes add targets outside the main Swanson deposit, but more drilling is needed to establish continuity.

The special committee will review formal materials before the board recommends a response; shareholders were told to take no action.

The Quebec grower has 15 of 24 Valleyfield rooms active and is still pursuing EU-GMP certification for its own processing centre.

Seraxis notes are expected to convert into BetaNova stock if the merger closes; the first SR-02 patient dose is targeted for Q1 2027.

The designation offers prioritized FDA interaction, while a pivotal study and separate clearance submission still lie ahead.

The Oct. 5 filing shows 29,462 bitcoin held on Oct. 2 as effective common and preferred share counts both rose over the prior week.

The Oct. 1 release says Inferize engineers joined Token Factory but gives no purchase price, integration timetable or sales target.

The North American agreement names no purchase value or delivery schedule as LG prepares a Virginia chiller plant for first-half 2027 production.

The planned notice would lift cash to US$1 and the cap to US$6 per share, and extend the current Dec. 1 expiry to Dec. 4.

The Oct. 5 release says Galam's first doré bar came from Merrill-Crowe cement, but gives neither the bar's weight nor a date for the pilot to reach nameplate capacity.

The second 500 MW phase is now planned for 2029, but Kentucky commission approval and the utility's construction schedule still govern delivery.

Stoke plans to combine four Vineland-3 subdomains for its U.S. NDA after a Phase 3 readout expected in the third quarter of 2027.

The three holes totalled 1,076.9 metres in Akyanga's northeastern zone and will inform targeting for a second drilling phase.

The vaccine met the stricter direct test for 17 of 19 serotypes shared with Capvaxive, with two meeting an older threshold.

The Reykjavik approval doubles drug substance capacity available for U.S. supply; separate biosimilar applications remain under FDA review.

A second rig has been procured for the 1,300-metre Saskatchewan program, with C$975,000 allocated to drilling.

BBA will study Lion and Nisk Main using the September resource estimate, with capital costs and preliminary economics targeted for the first half of 2027.

The Oct. 5 sale leaves 38.3 million previously issued shares unsold as the company targets a £17 million Coinbase loan balance.

The proposed truck-to-rail handoff at Matagami still needs a commercial contract, with service pricing and upgrade contributions to be negotiated.

The 125-patient single-arm study had no control group, while Medtronic says U.S. payer coverage reaches 96% of commercial and Medicare insured lives.

Two unnamed inference customers extend earlier deals, with QumulusAI targeting capacity turnover in December 2026 and early 2027.

The FDA label covers previously untreated adults with no known 17p deletion after a 282-patient trial against chemoimmunotherapy.

Among 109 treated patients, the median response lasted 12.1 months; the single-arm cohort offers no direct efficacy comparison.

The GL1 hole lies about 100 metres southeast of earlier drilling; assays from ten more holes in the completed program remain pending.

The company says the agency has set no new action date, while its U.S. launch target remains conditional on approval.

Bitdeer's Oct. 3 update lists zero pure bitcoin holdings as of Oct. 2 but gives no sale price, proceeds or mining costs.

The Nevada lithium study assumes US$24,000 per tonne of lithium carbonate and US$2.77 billion in first-phase capital.

Rebisufligene etisparvovec won U.S. approval on Sept. 17; Ultragenyx gave no date for a European decision.

The Oct. 1 close follows a 25 million share proposal, but the completion notices give no final ownership percentage or cash proceeds to the parent.

State approvals cleared the Oct. 1 transfer of certain Ohio operations; AYR disclosed no cash proceeds or debt relief figure.

One petition is active and the other pending review; both would let Florida medical operators sell to adults if voters approve.

The TSX Venture company has issued US$10.5 million of secured convertible notes and will seek shareholder approval for preferred shares on Oct. 14.